Cited by 3,162Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 104 of the 107 references it cites were found in a registry or an index, and 3 are not checked yet.

Clonal evolution in cancer

Open access

Greaves, Mel, Maley, Carlo C.·2012·Nature

DOI 10.1038/nature10762PMC PMC3367003

Open this paper in CoChat — free account

Abstract

Cancers evolve by a reiterative process of clonal expansion, genetic diversification and clonal selection within the adaptive landscapes of tissue ecosystems. The dynamics are complex, with highly variable patterns of genetic diversity and resulting clonal architecture. Therapeutic intervention may destroy cancer clones and erode their habitats, but it can also inadvertently provide a potent selective pressure for the expansion of resistant variants. The inherently Darwinian character of cancer is the primary reason for this therapeutic failure, but it may also hold the key to more effective control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature10762

Cites

104 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Önder, T. T., Jiang, G., Tao, K. X., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,429
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253

Show all 104 references

Sorted by citations

Items 301–400 of 1,004

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
Fack, F., Espedal, H., Keunen, O., Golebiewska, A., Obad, N., Harter, P. N., Mittelbronn, M. G. A., Bähr, O., Weyerbrock, A., Stuhr, L. E. B., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1352-5 · Cited by 146
Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes
Ullah, I., Karthik, G.-M., Alkodsi, A., Kjällquist, U., Stålhammar, G., Lövrot, J., Martinez, N.-F., Lagergren, J., Hautaniemi, S., Hartman, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96149 · Cited by 145
Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow
Gillies, R. J., Brown, J. S., Anderson, A. R. A., & Gatenby, R. A. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0030-7 · Cited by 143
Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches
Gupta, R. G., Li, F., Roszik, J., & Lizee, G. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1575 · Cited by 144
Flower isoforms promote competitive growth in cancer
Madan, E., Pelham, C. J., Nagane, M., Parker, T. M., Canas‐Marques, R., Fazio, K., Shaik, K., Yuan, Y., Henriques, V., Galzerano, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1429-3 · Cited by 146
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance
Saha, T., & Lukong, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856974 · Cited by 148
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
Türeci, Ö., Vormehr, M., Diken, M., Kreiter, S., Huber, C., & Şahin, U. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1509 · Cited by 148
Metabolic features of cancer stem cells: the emerging role of lipid metabolism
Mancini, R., Noto, A., Pisanu, M. E., Vitis, C. D., Maugeri‐Saccà, M., & Ciliberto, G. (2018) · Oncogene · doi:10.1038/s41388-018-0141-3 · Cited by 140
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures
Velde, R. V., Yoon, N., Marusyk, V., Durmaz, A., Dhawan, A., Miroshnychenko, D., Lozano‐Peral, D., Desai, B., Balynska, O. V., Poleszczuk, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16212-w · Cited by 141
Tumor microenvironment-mediated chemoresistance in breast cancer
Velaei, K., Samadi, N., Brazvan, B., & Rad, J. S. (2016) · The Breast · doi:10.1016/j.breast.2016.09.002 · Cited by 138
Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells
Perry, J. M., Fang, T., Roy, A., Lin, T. L., He, X., Chen, S., Lü, X., Nemechek, J. M., Ruan, L., Yu, X., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0507-y · Cited by 140
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing
Fang, L. T., Zhu, B., Zhao, Y., Chen, W., Yang, Z., Kerrigan, L., Langenbach, K. J., de Mars, M., Lu, C., Idler, K. B., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00993-6 · Cited by 129
Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint
Rueff, J., & Rodrigues, A. S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3347-1_1 · Cited by 144
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
Su, G.-H., Xiao, Y., You, C., Zheng, R., Zhao, S., Sun, S., Zhou, J.-Y., Lin, L., Wang, H., Shao, Z., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf0837 · Cited by 140
Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness
Nguyen, A., Yoshida, M., Goodarzi, H., & Tavazoie, S. F. (2016) · Nature Communications · doi:10.1038/ncomms11246 · Cited by 136
Understanding and overcoming multidrug resistance in cancer
Ge, M., Chen, X.-Y., Huang, P., Fleishman, J. S., Yang, D., Wu, Z., Ke, Z., & Chen, Z. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01059-1 · Cited by 145
Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors
Braakhuis, B. J. M., Brakenhoff, R. H., & Leemans, C. R. (2012) · Annals of Oncology · doi:10.1093/annonc/mds299 · Cited by 136
Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
Dutta, A. K., Fink, J. L., Grady, J. P., Morgan, G. J., Mullighan, C. G., To, L. B., Hewett, D. R., & Zannettino, A. C. W. (2018) · Leukemia · doi:10.1038/s41375-018-0206-x · Cited by 140
Subclonal reconstruction of tumors by using machine learning and population genetics
Caravagna, G., Heide, T., Williams, M. J., Zapata, L., Nichol, D., Chkhaidze, K., Cross, W. C. H., Cresswell, G. D., Werner, B., Acar, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0675-5 · Cited by 129
Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment
Pasha, N., & Turner, N. C. (2021) · Nature Cancer · doi:10.1038/s43018-021-00229-1 · Cited by 135
The mini-driver model of polygenic cancer evolution
Castro-Giner, F., Ratcliffe, P. J., & Tomlinson, I. P. M. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3999 · Cited by 133
Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
Cai, W., Lin, D., Wu, C., Li, X., Zhao, C., Zheng, L.-M., Chuai, S., Fei, K., Zhou, C., & Hirsch, F. R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8293 · Cited by 134
Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma
Kaur, N., Chettiar, S. T., Rathod, S. S., Rath, P., Muzumdar, D., Shaikh, M. L., & Shiras, A. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.01.001 · Cited by 133
Objective assessment of cancer genes for drug discovery
Patel, M. N., Halling‐Brown, M., Tym, J. E., Workman, P., & Al‐Lazikani, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3913 · Cited by 133
Spatial structure governs the mode of tumour evolution
Noble, R., Bürri, D., Sueur, C. L., Lemant, J., Viossat, Y., Kather, J. N., & Beerenwinkel, N. (2021) · Nature Ecology & Evolution · doi:10.1038/s41559-021-01615-9 · Cited by 139
Molecular Pathology of Breast Cancer
Allison, K. H. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcpiv9iq1mrqmoo · Cited by 131
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes
Marusyk, A., Tabassum, D. P., Janiszewska, M., Place, A. E., Trinh, A. C., Rozhok, A. I., Pyne, S., Guerriero, J. L., Shu, S., Ekram, M. B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1457 · Cited by 129
Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies
Lorz, A., Lorenzi, T., Hochberg, M., Clairambault, J., & Benoît Perthame, B. (2012) · ESAIM Mathematical Modelling and Numerical Analysis · doi:10.1051/m2an/2012031 · Cited by 132
The co-evolution of the genome and epigenome in colorectal cancer
Heide, T., Househam, J., Cresswell, G. D., Spiteri, I., Lynn, C., Mossner, M., Kimberley, C., Fernández-Mateos, J., Chen, B., Zapata, L., et al. (2022) · Nature · doi:10.1038/s41586-022-05202-1 · Cited by 129
m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma
Fang, H., Sun, Q., Zhou, J., Zhang, H., Song, Q., Zhang, H., Yu, G., Guo, Y., Huang, C., Mou, Y., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01791-1 · Cited by 137
Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies
Mina, M., Raynaud, F., Tavernari, D., Battistello, E., Sungalee, S., Saghafinia, S., Laessle, T., Sanchez-Vega, F., Schultz, N., Oricchio, E., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.010 · Cited by 129
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
Casuscelli, J., Weinhold, N., Gundem, G., Wang, L., Zabor, E. C., Drill, E. N., Wang, P. I., Nanjangud, G. J., Redzematovic, A., Nargund, A. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92688 · Cited by 131
De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry
Balluff, B., Frese, C. K., Maier, S. K., Schöne, C., Küster, B., Schmitt, M., Aubele, M. M., Höfler, H., Deelder, A. M., Heck, A. J. R., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4436 · Cited by 128
Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
da Cunha, B. R., Domingos, C., Stefanini, A. C. B., Henrique, T., Polachini, G. M., Castelo‐Branco, P., & Tajara, E. H. (2019) · Journal of Cancer · doi:10.7150/jca.21780 · Cited by 133
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma
Sun, Y., Wu, P., Zhang, Z., Wang, Z., Zhou, K., Song, M., Ji, Y., Zang, F., Lou, L., Rao, K., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.11.010 · Cited by 133
Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis
Dybkær, K., Bøgsted, M., Falgreen, S., Bødker, J. S., Kjeldsen, M. K., Schmitz, A., Bilgrau, A. E., Xu-Monette, Z. Y., Li, L., Bergkvist, K. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.7080 · Cited by 128
Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
Werner, S. L., Graf, R. P., Landers, M. A., Valenta, D. T., Schroeder, M. J., Greene, S. B., Bales, N., Dittamore, R. V., & Marrinucci, D. C. (2015) · Journal of Circulating Biomarkers · doi:10.5772/60725 · Cited by 131
Cancer stem cell: Fundamental experimental pathological concepts and updates
Islam, F., Qiao, B., Smith, R. A., Gopalan, V., & Lam, A. K.-Y. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.02.002 · Cited by 131
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Nguyen, V. T. M., Barozzi, I., Faronato, M., Lombardo, Y., Steel, J. H., Patel, N. R., Darbre, P. D., Castellano, L., Győrffy, B., Woodley, L., et al. (2015) · Nature Communications · doi:10.1038/ncomms10044 · Cited by 125
In silico saturation mutagenesis of cancer genes
Muiños, F., Martínez-Jiménez, F., Pich, O., González-Pérez, A., & López-Bigas, N. (2021) · Nature · doi:10.1038/s41586-021-03771-1 · Cited by 125
TrAp: a tree approach for fingerprinting subclonal tumor composition
Strino, F., Parisi, F., Micsinai, M., & Kluger, Y. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt641 · Cited by 126
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia
Malinowska-Ozdowy, K., Frech, C., Schönegger, A., Eckert, C., Cazzaniga, G., Stanulla, M., Stadt, U. Z., Mecklenbräuker, A., Schuster, M. K., Kneidinger, D., et al. (2015) · Leukemia · doi:10.1038/leu.2015.107 · Cited by 128
The cancer biology of whole-chromosome instability
Duijf, P. H. G., & Benezra, R. (2013) · Oncogene · doi:10.1038/onc.2012.616 · Cited by 125
Origins of aberrant DNA methylation in acute myeloid leukemia
Schoofs, T., Berdel, W. E., & Müller‐Tidow, C. (2013) · Leukemia · doi:10.1038/leu.2013.242 · Cited by 127
Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
Butler, E. B., Zhao, Y., Muñoz‐Pinedo, C., Lu, J., & Tan, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3009 · Cited by 126
How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient
Hansen, E., Woods, R. J., & Read, A. F. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2001110 · Cited by 123
Image-guided genomics of phenotypically heterogeneous populations reveals vascular signalling during symbiotic collective cancer invasion
Konen, J. M., Summerbell, E. R., Dwivedi, B., Galior, K. D., Hou, Y., Rusnak, L., Chen, A., Saltz, J. H., Zhou, W., Boise, L., et al. (2017) · Nature Communications · doi:10.1038/ncomms15078 · Cited by 124
Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells
Rahn, S., Zimmermann, V., Viol, F., Knaack, H., Stemmer, K., Peters, L., Lenk, L., Ungefroren, H., Saur, D., Schäfer, H., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.004 · Cited by 124
Multiple myeloma clonal evolution in homogeneously treated patients
Corre, J., Cleynen, A., Robiou-du-Pont, S., Buisson, L., Bolli, N., Attal, M., Munshi, N. C., & Avet‐Loiseau, H. (2018) · Leukemia · doi:10.1038/s41375-018-0153-6 · Cited by 128
Exploiting evolutionary steering to induce collateral drug sensitivity in cancer
Acar, A., Nichol, D., Fernández-Mateos, J., Cresswell, G. D., Barozzi, I., Hong, S. P., Trahearn, N., Spiteri, I., Stubbs, M., Burke, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15596-z · Cited by 137
Self-citation
Microfluidic enrichment for the single cell analysis of circulating tumor cells
Yeo, T., Tan, S. J., Lim, C. L., Lau, D. P. X., Chua, Y. W., Krisna, S. S., Iyer, G., Tan, G. S., Lim, T. K. H., Tan, D. S. W., et al. (2016) · Scientific Reports · doi:10.1038/srep22076 · Cited by 123
Minor clone provides a reservoir for relapse in multiple myeloma
Magrangeas, F., Avet‐Loiseau, H., Gouraud, W., Lodé, L., Decaux, O., Godmer, P., Garderet, L., Voillat, L., Facon, T. T. F., Stoppa, A., et al. (2012) · Leukemia · doi:10.1038/leu.2012.226 · Cited by 122
Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines
Januchowski, R., Wojtowicz, K., Sterzyńska, K., Sosisska, P., Andrzejewska, M., Zawierucha, P., Nowicki, M. O., & Zabel, M. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.017 · Cited by 121
Nanoplasmonic sensors for detecting circulating cancer biomarkers
Ferhan, A. R., Jackman, J. A., Park, J. H., Cho, N., & Kim, D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.004 · Cited by 119
Non-random Mis-segregation of Human Chromosomes
Worrall, J. T., Tamura, N., Mazzagatti, A., Shaikh, N., van Lingen, T., Bakker, B., Spierings, D. C. J., Vladimirou, E., Foijer, F., & McClelland, S. E. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.047 · Cited by 113
Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data
Oesper, L., Satas, G., & Raphael, B. J. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu651 · Cited by 114
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment
Eguchi, T., Sogawa, C. A., Okusha, Y., Uchibe, K., Iinuma, R., Ono, K., Nakano, K., Murakami, J., Itoh, M., Arai, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191109 · Cited by 123
Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle–Related Transcription and Attenuated Androgen Response
Horning, A. M., Wang, Y., Lin, C.-K., Louie, A. D., Jadhav, R. R., Hung, C., Wang, C., Lin, C.-L., Kirma, N. B., Liss, M. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1924 · Cited by 117
Single cell analysis of cancer genomes
Loo, P. V., & Voet, T. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.004 · Cited by 118
FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia
Leung, A. Y. H., Man, C., & Kwong, Y. (2012) · Leukemia · doi:10.1038/leu.2012.195 · Cited by 117
5-Fluorouracil Chemotherapy of Gastric Cancer Generates Residual Cells with Properties of Cancer Stem Cells
Xu, Z., Tang, J., Xie, H., Du, Y., Huang, L., Yu, P., & Cheng, X. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10248 · Cited by 121
Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance
Lee, G., & Hall, R. R. (2016) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000363 · Cited by 123
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia
Tzoneva, G., Dieck, C. L., Oshima, K., Ambesi‐Impiombato, A., Sánchez-Martín, M., Madubata, C. J., Khiabanian, H., Yu, J., Waanders, E., Iacobucci, I., et al. (2018) · Nature · doi:10.1038/nature25186 · Cited by 117
Predictive validity in drug discovery: what it is, why it matters and how to improve it
Scannell, J. W., Bosley, J., Hickman, J. A., Dawson, G. R., Truebel, H., Ferreira, G. S., Richards, D. B., & Treherne, J. M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00552-x · Cited by 126
Tumor growth dynamics: insights into evolutionary processes
Rodriguez-Brenes, I. A., Komarova, N. L., & Wodarz, D. (2013) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2013.05.020 · Cited by 116
Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples
Oh, E., Choi, Y., Kwon, M. J., Kim, R. N., Kim, Y. J., Song, J., Jung, K. S., & Shin, Y. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144162 · Cited by 115
Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications
Valdés-Rives, S. A., Casique‐Aguirre, D., German‐Castelan, L., Velasco-Velázquez, M. A., & González‐Arenas, A. (2017) · BioMed Research International · doi:10.1155/2017/7403747 · Cited by 117
Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer
Findlay, V. J., Wang, C., Watson, D. K., & Camp, E. R. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.15 · Cited by 114
The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer
Jeselsohn, R. M., Angelis, C. D., Brown, M. A., & Schiff, R. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0591-8 · Cited by 112
Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer
Bassiouni, R., Idowu, M. O., Gibbs, L. D., Robila, V., Grizzard, P. J., Webb, M. G., Song, J., Noriega, A., Craig, D. W., & Carpten, J. D. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2682 · Cited by 119
SiCloneFit: Bayesian inference of population structure, genotype, and phylogeny of tumor clones from single-cell genome sequencing dataPreprint
Zafar, H., Navin, N. E., Chen, K., & Nakhleh, L. K. (2019) · Genome Research · doi:10.1101/gr.243121.118 · Cited by 113
The impact of intra-clonal heterogeneity on the treatment of multiple myeloma
Brioli, A., Melchor, L., Cavo, M., & Morgan, G. J. (2014) · British Journal of Haematology · doi:10.1111/bjh.12805 · Cited by 116
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics
Collins, D. C., Sundar, R., Lim, J. S. J., & Yap, T. A. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.10.012 · Cited by 116
Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes
Stieber, D., Golebiewska, A., Evers, L., Lenkiewicz, E., Brons, N. H. C., Nicot, N., Oudin, A., Bougnaud, S., Hertel, F., Bjerkvig, R., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1196-4 · Cited by 112
Negative selection in tumor genome evolution acts on essential cellular functions and the immunopeptidome
Zapata, L., Pich, O., Serrano, L. G., Kondrashov, F. A., Ossowski, S., & Schaefer, M. H. (2018) · Genome biology · doi:10.1186/s13059-018-1434-0 · Cited by 110
Mapping the spreading routes of lymphatic metastases in human colorectal cancer
Zhang, C., Zhang, L., Xu, T., Xue, R., Yu, L., Zhu, Y.-L., Wu, Y., Zhang, Q., Li, D., Shen, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15886-6 · Cited by 112
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma
Cammareri, P., Rose, A., Vincent, D. F., Wang, J., Nagano, A., Libertini, S., Ridgway, R. A., Athineos, D., Coates, P. J., McHugh, A. T., et al. (2016) · Nature Communications · doi:10.1038/ncomms12493 · Cited by 116
Targeting Membrane Lipid a Potential Cancer Cure?
Tan, L. T., Chan, K., Pusparajah, P., Lee, W.-L., Chuah, L., Khan, T. M., Lee, L., & Goh, B. H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00012 · Cited by 114
Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression
Liao, Z., Jiang, W., Ye, L., Li, T., Yu, X., & Liu, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188392 · Cited by 110
Protecting the normal in order to better kill the cancer
Liu, B., Ezeogu, L., Zellmer, L., Yu, B., Xu, N., & Liao, D. J. (2015) · Cancer Medicine · doi:10.1002/cam4.488 · Cited by 111
From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells
van Nieuwenhuijzen, N., Spaan, I., Raymakers, R. A. P., & Peperzak, V. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3115 · Cited by 116
The translational challenges of precision oncology
Pich, O., Bailey, C., Watkins, T. B. K., Zaccaria, S., Jamal‐Hanjani, M., & Swanton, C. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.04.002 · Cited by 116
Intratumoral heterogeneity and drug resistance in cancer
Fu, Y.-C., Liang, S.-B., Luo, M., & Wang, X. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03734-w · Cited by 129
Predicting relapse risk in childhood acute lymphoblastic leukaemia
Teachey, D. T., & Hunger, S. P. (2013) · British Journal of Haematology · doi:10.1111/bjh.12442 · Cited by 117
Cancer in Light of Experimental Evolution
Sprouffske, K., Merlo, L. M. F., Gerrish, P. J., Maley, C. C., & Sniegowski, P. (2012) · Current Biology · doi:10.1016/j.cub.2012.06.065 · Cited by 110
Self-citation
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML
Wong, T. N., Miller, C. A., Klco, J. M., Petti, A. A., Demeter, R., Helton, N., Li, T., Fulton, R. S., Heath, S. E., Mardis, E. R., et al. (2015) · Blood · doi:10.1182/blood-2015-10-677021 · Cited by 108
Visible to near-infrared refractive properties of freshly-excised human-liver tissues: marking hepatic malignancies
Giannios, P., Toutouzas, K. G., Matiatou, M., Stasinos, K., Konstadoulakis, M. M., Zografos, G., & Moutzouris, K. (2016) · Scientific Reports · doi:10.1038/srep27910 · Cited by 108
Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine
Aleskandarany, M. A., Vandenberghe, M. E., Marchiò, C., Ellis, I. O., Sapino, A., & Rakha, E. A. (2018) · Pathobiology · doi:10.1159/000477851 · Cited by 114
Microvesicles as Mediators of Intercellular Communication in Cancer
Antonyak, M. A., & Cerione, R. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0856-1_11 · Cited by 113
Single-cell mutational profiling and clonal phylogeny in cancer
Potter, N. E., Ermini, L., Papaemmanuil, E., Cazzaniga, G., Vijayaraghavan, G., Titley, I., Ford, A., Campbell, P., Kearney, L., & Greaves, M. (2013) · Genome Research · doi:10.1101/gr.159913.113 · Cited by 107
Self-citation
Targeting tumor suppressor genes for cancer therapy
Liu, Y., Hu, X., Han, C., Wang, L., Zhang, X., He, X., & Lu, X. (2015) · BioEssays · doi:10.1002/bies.201500093 · Cited by 112
Hypoxia and HIF pathway in cancer and the placenta
Macklin, P. S., McAuliffe, J., Pugh, C. W., & Yamamoto, A. (2017) · Placenta · doi:10.1016/j.placenta.2017.03.010 · Cited by 111
Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery
Huang, H., Rizvi, I., Liu, J., Anbil, S. R., Kalra, A. V., Lee, H., Baglo, Y., Paz, N., Hayden, D., Pereira, S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1700 · Cited by 109
Multicolour lineage tracing reveals clonal dynamics of squamous carcinoma evolution from initiation to metastasis
Reeves, M. Q., Kandyba, E. E., Harris, S., Rosario, R. D., & Balmain, A. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0109-0 · Cited by 100
Isolating live cell clones from barcoded populations using CRISPRa-inducible reporters
Umkehrer, C., Holstein, F., Formenti, L., Jude, J., Froussios, K., Neumann, T., Cronin, S. M., Haas, L., Lipp, J., Burkard, T. R., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0614-0 · Cited by 103
An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer
Maley, C. C., Koelble, K., Natrajan, R., Aktipis, A., & Yuan, Y. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0638-4 · Cited by 104
Self-citation
CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis
Liu, R., Wei, H., Gao, P., Yu, H., Wang, K., Fu, Z., Ju, B., Zhao, M., Dong, S., Li, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16547 · Cited by 104
Heterogeneity in renal cell carcinoma
Beksac, A. T., Paulucci, D. J., Blum, K. A., Yadav, S. S., Sfakianos, J. P., & Badani, K. K. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.05.006 · Cited by 111
Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review
Kazerooni, A. F., Bakas, S., Rad, H. S., & Davatzikos, C. A. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26907 · Cited by 104
Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells
Pienta, K. J., Hammarlund, E. U., Brown, J. S., Amend, S. R., & Axelrod, R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020838118 · Cited by 103

Authors: Greaves, M., & Maley, C. C.
Affiliations: University of California, San Francisco (US)
ORCID: Maley, Carlo C.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2012-01
Volume: 481
Issue: 7381
Pages: 306-313
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10762
PMC: PMC3367003
OpenAlex: W2023560061
Cited by: 3,162
References: 104
Citations by year: 2026: 180 · 2025: 160 · 2024: 181 · 2023: 225 · 2022: 204 · 2021: 253 · 2020: 229 · 2019: 211 · 2018: 247 · 2017: 296 · 2016: 247 · 2015: 238 · 2014: 221 · 2013: 164 · 2012: 101
FWCI: 17.27
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Cancer Institute (R01CA149566, P01CA091955, U54CA143803, P01CA91955, R01CA140657)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, cancer, clonal expansion, genetic diversification, clonal selection, fitness landscape, tumor microenvironment, clonal architecture, drug resistance
MeSH terms: Animals, Clone Cells, Humans, Mutation, Neoplasms, Neoplastic Stem Cells, Genomics, Tumor Microenvironment, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clonal evolution in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks